Discover if this is a suitable investor for your startup. If they are we'll make a warm introduction for free. Otherwise, we'll connect you with matching investors.
Martlet Capital is an early-stage venture capital firm based in Cambridge, UK, founded in 2011. The firm specializes in providing patient capital to startups in the deep technology and life sciences sectors, particularly those with high growth potential. Since its inception, Martlet Capital has invested in over 70 startups, demonstrating a strong commitment to fostering innovation in these critical areas. The firm is owned and managed by EMV Capital, which provides a structured operational backing that enhances its investment capabilities.
Martlet Capital's reputation in the venture capital landscape is bolstered by its successful track record of exits, including notable companies such as Abcam and Frontier Developments. These exits reflect the firm's strategic approach to identifying and nurturing startups that are poised for significant growth. With a focus on B2B startups, Martlet Capital aims to support entrepreneurs who are developing transformative technologies that can impact various industries.
Martlet Capital's investment focus is primarily on deep technology and life sciences sectors, with a specific emphasis on pre-seed and seed stage companies. The firm actively seeks to invest in startups that are innovating in areas such as artificial intelligence, digital health, genomics, robotics, and sustainable technologies. This targeted approach allows Martlet Capital to leverage its expertise and network to support entrepreneurs in navigating the complexities of early-stage development.
The firm looks for companies that demonstrate a clear value proposition and the potential for substantial market impact. By concentrating on high-growth sectors, Martlet Capital aims to partner with visionary founders who are committed to pushing the boundaries of technology and improving healthcare outcomes. Their investment thesis is designed to foster innovation and drive advancements in critical areas that can benefit society at large.
Martlet Capital boasts a diverse portfolio of over 70 companies, showcasing its commitment to investing in innovative startups. Notable investments include **Abcam**, a leading supplier of protein research tools that is publicly listed on the London Stock Exchange, and **Frontier Developments**, a prominent video game developer and publisher also listed on the LSE. Other significant portfolio companies include **Arachnys**, which provides intelligent risk and compliance technology, and **Audio Analytic**, known for its intelligent sound detection technology.
Additionally, Martlet Capital has backed **Cambridge CMOS Sensors**, a company specializing in semiconductor-based gas sensor solutions that was acquired by AMS AG, and **Vantage Power**, which focuses on powertrain electrification for heavy-duty vehicles and was acquired by Allison Transmission. Other notable companies in their portfolio include IESO Digital Health, NU Quantum, and Xampla, reflecting the firm's strategic focus on high-potential startups across various sectors.
To pitch Martlet Capital, founders should email contactus@martletcap.com. It is recommended to include a concise overview of the startup, highlighting its unique value proposition and alignment with Martlet's investment focus on deep technology and life sciences.
Martlet Capital primarily invests in pre-seed and seed stage companies. This focus allows them to support early-stage startups that are developing innovative technologies in their target sectors.
Founders interested in pitching to Martlet Capital can reach out via email at contactus@martletcap.com. It is advisable to provide a clear overview of the business model, market opportunity, and how the startup aligns with their investment focus.
Martlet Capital focuses on deep technology and life sciences sectors. They are particularly interested in startups innovating in artificial intelligence, digital health, genomics, robotics, and sustainable technologies.
The specific check size is not detailed in the source material. However, as an early-stage investor, Martlet Capital typically invests amounts suitable for pre-seed and seed stage companies.
Martlet Capital primarily invests in the United Kingdom, focusing on startups that are based in or have a significant presence in the region.
While specific details on portfolio support are not provided, Martlet Capital's backing by EMV Capital suggests that they offer operational support and strategic guidance to their portfolio companies.
All trademarks, logos and brand names are the property of their respective owners. All company, product and service names used in this website are for identification purposes only. Use of these names, trademarks, and brands does not imply endorsement.